1. Introduction {#s0005}
===============

Bipolar Disorder (BD) is a complex disorder characterized by mood dysregulation resulting in significant psychosocial impairment ([@bb0305]). Family, twin, adoption and genome-wide association (GWAS) studies have consistently shown a substantial genetic contribution to disease etiology ([@bb0280], [@bb0010]) with heritability estimates ranging from 0.6 to 0.8 ([@bb0280], [@bb0190]). It is widely acknowledged that the genetic architecture of the BD is polygenic and consistent with a threshold-liability model ([@bb0130]). Candidate gene and GWAS genetic studies have identified a number of single-nucleotide polymorphisms (SNPs) that are associated with increased risk for BD ([@bb0160], [@bb0265], [@bb0135]). Individual risk-alleles for BD have been shown to influence brain structure and function in healthy individuals ([@bb0170], [@bb0020], [@bb0095], [@bb0125], [@bb0180], [@bb0325], [@bb0150], [@bb0230]), patients with BD ([@bb0205], [@bb0240], [@bb0030], [@bb0260], [@bb0285], [@bb0070], [@bb0295]) and their unaffected relatives ([@bb0185], [@bb0165], [@bb0330], [@bb0090], [@bb0055]). Collectively, these studies have established that risk-variants for BD are linked to brain alterations considered relevant to the pathophysiology of the disorder. For example, meta-analyses of functional magnetic resonance imaging (fMRI) studies have consistently shown increased activation in the amygdala and decreased activation in the ventrolateral prefrontal cortex (vlPFC) across a number of cognitive tasks in patients with BD compared to healthy controls ([@bb0040], [@bb0060]). Similarly, GWAS-supported risk-alleles in the CACNA1C and ANK3 genes, have been independently associated with increased amygdalar activity in patients with BD ([@bb0070], [@bb0165]) and in the vlPFC ([@bb0165]).

However, individual GWAS-supported genetic loci only account for a very small fraction of the risk of BD ([@bb0310]). In response, the polygenic risk (PGR) score method has been developed to quantify the extent to which common risk-variants may collectively capture variation in susceptibility to disease ([@bb0160]). The PGR score for BD (PGR-BD) is calculated in each individual by aggregating variation across GWAS loci nominally associated with BD into a quantitative score ([@bb0160], [@bb0065]), with the current PGR-BD explaining \~ 5% of the variance to BD ([@bb0050]). Two previous studies have used the polygenic risk score method to examine the cumulative impact of BD-related risk-conferring SNPs on task-related brain activation during an emotional processing ([@bb0290]) and a word generation task ([@bb0330]). During emotional processing, a positive association was found in patients with BD and in controls between PRG-BD score and brain activation in the right vlPFC. In the word generation task a positive association was also present between the PGR-BD score and amygdalar activation in unaffected relatives of patients and in controls. Neither study found an interaction between PGR-BD score and diagnostic group on the patterns of brain activation. This evidence collectively suggests that the influence of common risk-alleles on brain function may be more informative with regards to brain phenotypes related to vulnerability to BD rather than overt disease. The PGR method has a relatively higher explanatory power compared to single SNP examinations ([@bb0065]), and may be useful in identifying regions where the additive effect of common risk-alleles converges to confer vulnerability to BD.

Based on the above we examined the effect of a PGR-BD on brain fMRI data from patients with BD, unaffected relatives and unrelated healthy controls while performing a facial affect and a working memory processing task. Current models of BD emphasise increased neural response to affective stimuli coupled with reduced efficacy of the neural systems responsible for cognitive control ([@bb0245], [@bb0025]). We therefore chose the facial affect and working memory tasks as the former maps onto the ventral PFC-limbic pathway ([@bb0085], [@bb0315]) implicated in the ability to process the emotional significance of stimuli and the later engages frontoparietal regions involved in cognitive control ([@bb0075], [@bb0210], [@bb0220]). Additionally, previous studies have reported brain functional abnormalities in patients with BD while performing these tasks ([@bb0025]) thus demonstrating their relevance to BD. Using two different paradigms on the same study sample we aimed to test whether the polygenic load for BD has a localized effect to a region or a network of regions that are task dependent and may represent a common pathway linking genetic risk to BD-related brain abnormalities.

2. Material and methods {#s0010}
=======================

2.1. Participants {#s0015}
-----------------

Euthymic patients with BD (n = 41), their unaffected first-degree relatives (n = 25) and demographically matched unrelated healthy individuals (n = 46) were selected from the VIBES study ([@bb0120]) ([Table 1](#t0005){ref-type="table"}). All participants were of white British ancestry. They were assessed using the structured clinical interview for the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, revised (DSM-IV) for Axis I diagnoses ([@bb0110], [@bb0115]). Patients that fulfilled the criteria for BD, type I according to the DSM-IV ([@bb0015]) were included. The relatives were carefully selected from the VIBES sample based on the absence of any lifetime history of psychopathology. The sample included 17 BD patients-sibling pairs from 17 different families. Unrelated healthy individuals were selected based on the absence of family history and personal lifetime history of psychiatric disorders. In all participants, current IQ was assessed using the Wechsler Adult Intelligence Scale 3rd Edition ([@bb0320]) and psychopathology was rated using the Hamilton Depression Rating Scale ([@bb0145]) (HDRS), Young Mania Rating Scale ([@bb0345]) (YMRS) and Brief Psychiatric Rating Scale ([@bb0195]) (BPRS). Psychopathology was assessed weekly in patients over a period of 1 month prior to testing and at each assessment they scored below 7 in the HDRS and YMRS. Patients were also required to have remained on the same type and dose of medication for a minimum of 6 months. The BPRS, HDRS and YMRS scores were highly correlated (all r \> 0.73, p \< 0.0001). To avoid collinearity we used the total BPRS score as a covariate in subsequent neuroimaging analyses because, unlike the two other scales, it is applicable to nonclinical populations.

2.2. DNA extraction and genotyping {#s0020}
----------------------------------

We obtained DNA from the participants using buccal swabs and conventional procedures. All participants were genotyped on the Psych Chip (Illumina Infinium PsychArray-24). Data quality was controlled in PLINK v1.07 ([@bb0270]) using the same parameters as described in [@bb0045]. SNPs were excluded when missingness \> 1%, minor allele frequency (MAF) \< 0.01 or Hardy-Weinberg equilibrium (HWE) \< 0.00001 and participants were excluded when missingness \> 1%. Sex and relatedness checks were carried out, in addition to principal component analyses to confirm self-reported ethnicities ([@bb0225]).

2.3. Polygenic risk scores {#s0025}
--------------------------

Genome-wide polygenic risk scores for BD (PGR-BD) were generated with the PRSice software (<http://prsice.info/;> [@bb0100]) using the most recent Psychiatric Genomics Consortium (PGC) GWAS of BD from the cross disorder study ([@bb0050]). The SNPs used were those selected by the analysts of those studies using P-value-informed clumping in PLINK with a cut-off of r^2^ = 0.25 within a 200-kb window, and excluding the Major Histocompatibility Complex (MHC) region of the genome because of its complex linkage disequilibrium structure. Of 108,834 clumped SNPs from the original analyses of BD, 108,217 existed in our data. For each participant, seven PGR-BD scores were generated using SNPs with p-values \< 0.001 (SNPs: 417), 0.05 (SNPs: 9715), 0.1 (SNPs: 16,691), 0.2 (SNPs: 28,450), 0.3 (SNPs: 38,207), 0.4 (SNPs: 46,753) and 0.5 (SNPs: 54,127).

2.4. Facial affect recognition paradigm {#s0030}
---------------------------------------

Three negative facial emotions (fear, anger and sadness) were examined in three event-related experiments presented in a random order during a single acquisition session. In each experiment, 10 different facial identities ([www.paulekman.com](http://www.paulekman.com){#ir0010}) depicting 150% intensity of an affective or a neutral facial expression were presented in a pseudorandom order interspersed with a fixation cross. Each stimulus (affect and neutral faces; fixation cross) was displayed for 2 s and repeated 20 times. Participants were instructed to indicate whether the face was emotional or neutral. Response time and accuracy data were collected.

2.5. Working memory paradigm {#s0035}
----------------------------

The 2-back task was presented as an alternating block paradigm incorporating the active (2-back) and baseline (0-back) conditions. Participants were instructed to respond to target letters by button press. In the baseline condition, participants responded to the X letter. In the 2-back condition participants responded when the letter presented matched the one in the preceding 2 trials. Each stimulus was presented for 2 s. There were 18 epochs in all, each lasting 30 s. Response time and accuracy data were collected.

2.6. Image acquisition {#s0040}
----------------------

Anatomical and functional imaging data were acquired during the same session using a General Electric Sigma 1.5 Tesla. A high-resolution T1-weighted structural image was acquired for each participant in the same session in the axial plane for co-registration (inversion recovery prepared, spoiled gradient-echo sequence; repetition time = 18 ms, echo time = 5.1 ms, flip angle = 20°, slice thickness = 1.5 mm, matrix size = 256 ∗ 192, field of view = 240 ∗ 180 mm, voxel dimensions = 0.9375 ∗ 0.9375 ∗ 1.5 mm).

For the facial affect recognition paradigm, 450 T2-weighted MR images reporting blood-oxygen-level dependent (BOLD) contrast were acquired (repetition time = 2000 ms, echo time = 40 ms, flip angle = 70°, slice thickness = 7 mm, matrix size = 64 ∗ 64, voxel dimensions = 3.75 ∗ 3.75 ∗ 7.7 mm). For the 2-back paradigm, a total of 180 T2-weighted MR volumes depicting BOLD contrast were acquired (repetition time = 3000 ms, echo time = 40 ms, flip angle = 90°, slice thickness = 3 mm, matrix size = 64 ∗ 64, voxel dimensions = 3.75 ∗ 3.75 ∗ 3.30 mm).

2.7. Functional neuroimaging data analysis {#s0045}
------------------------------------------

Data were analysed in SPM8 ([www.fil.ion.ucl.ac.uk/spm/software/spm8/](http://www.fil.ion.ucl.ac.uk/spm/software/spm8/){#ir0015}). Data from each paradigm were analysed separately. For both paradigms, fMRI images were realigned, normalized and smoothed using an 8-mm full-width-half maximum Gaussian kernel. For the facial affect recognition paradigm, each participant\'s fMRI data from the three event-related experiments (fear, anger or sadness) were concatenated and vectors of onset representing correct responses were convolved with a canonical hemodynamic response function. The means of the three sessions as well as the transition at the end of each session were also modelled and images for the affect \> neutral faces contrast were produced for each participant. For the 2-back paradigm, the smoothed single-participant images were analysed using the linear convolution model, with vectors of onset representing the active (2-back) and baseline (0-back) condition. For each participant, images for the 2-back \> baseline contrast were produced.

2.8. Effect of PGR-BD score on task-related activation {#s0050}
------------------------------------------------------

For each task separately, contrast images from each participant were entered into second-level analyses using one-sample t-tests to identify clusters of increased task-related activation at p \< 0.05 with Family Wise Error (FWE) correction and cluster size (k) \> 20. The BPRS total score and relatedness were added as covariates. Beta value from the supra-threshold clusters were then extracted using the eigenvariate function in SPM8 and entered into a multivariate model to examine the effect of PGR-BD and its interaction with group (BD patients, unaffected relatives, unrelated healthy controls) in SPSS22, with relatedness as a covariate.

2.9. Effect of PGR-BD score on group differences on task-related activation {#s0055}
---------------------------------------------------------------------------

The effect of group (patients, relatives controls) was examined separately for each paradigm (affect faces \> neutral faces; 2-back \> baseline) using a general lineal model in SMP8 with the BPRS total score as covariate. In each of these analyses, supra-threshold clusters signifying group differences were identified using FWE correction of p \< 0.05, k \> 20. Beta values were extracted from each supra-threshold cluster using the eigenvariate function in SPM8. To test whether the PGR-BD score explained additional variance in group differences, Pearson\'s correlation analyses were used to examine the relationship between mean signal change in the suprathreshold clusters and PGR-BD score in SPSS22, with relatedness as a covariate.

3. Results {#s0060}
==========

3.1. Polygenic risk scores {#s0065}
--------------------------

We used one-way analysis of variance to compare patients, relatives, controls on PGR-BD scores derived using seven statistical thresholds (i.e., using SNPs with p-values \< 0.001, 0.05, 0.1, 0.2, 0.3, 0.4 and 0.5). Although the effect of group was significant at all thresholds, the highest difference (F = 5.94, p = 0.004) was found for the PGR-BD score using 16,691 SNPs with p \< 0.1. This PGR-BD score was higher in patients than controls (p = 0.002) while in relatives it was numerically intermediated between that of patients (p = 0.06) and controls (p = 0.09) ([Table 1](#t0005){ref-type="table"}). All subsequent analyses and results refer to this PGR-BD score. In the patient group, no significant correlations were found between PGR-BD and symptom severity (based on the total score of the HDRS, YMRS and BPRS), age of onset, duration of illness, and number of depressive and manic episodes (p \> 0.27).

3.2. Behavioural task performance {#s0070}
---------------------------------

Details of task performance are shown in [Table 1](#t0005){ref-type="table"}. Patients\' medication type and dose did not correlate with performance on either task (all p \> 0.40). In the facial affect recognition paradigm, we found a main effect of group on response time (p = 0.004), with BD patients being slower than the other two groups (p \< 0.007). However, the PGR-BD score showed a significant negative correlation with response time to affect compared to neutral faces when controlling for group (r = − 0.31, p = 0.003). In the 2-back task, there was no effect of group and no significant correlations were found between PGR-BD score and task performance.

3.3. Effect of PGR-BD on task-related activation {#s0075}
------------------------------------------------

### 3.3.1. Facial affect recognition {#s0080}

In all participants, activation in the affect \> neutral faces contrast was found in the visual association and prefrontal cortical areas (Supplemental Table 1; [Fig. 1](#f0005){ref-type="fig"}A). There was a main effect of PGR-BD score (F = 2.03, p = 0.04) but no group by PGR-BD interaction (F = 0.99, p = 0.46). The PGR-BD score influenced mean signal change in the visual cortex (peak MNI coordinates at: x = − 32, y = − 88, z = 2; *p* = 0.006) ([Fig. 1](#f0005){ref-type="fig"}B).

### 3.3.2. Working memory {#s0085}

In all participants, activation in 2-back \> baseline contrast was found in the ventral and dorsal lateral prefrontal cortex and in the parietal cortex (Supplemental Table 1; [Fig. 2](#f0010){ref-type="fig"}A). There was a main effect of PGR-BD score (F = 2.83, p = 0.01) but no group by PGR-BD interaction (F = 1.13, p = 0.33). The PGR-BD score influenced mean signal change in medial prefrontal cortex (peak MNI coordinates at: x = 22, y = 48, z = − 14; p = 0.004) ([Fig. 2](#f0010){ref-type="fig"}B).

3.4. Effect of PGR-BD on group differences on task-related activation {#s0090}
---------------------------------------------------------------------

### 3.4.1. Facial affect recognition {#s0095}

In the contrast affect \> neutral faces, an effect of group was noted in the anterior cingulate cortex (ACC) and right superior frontal gyrus, where BD patients showed, respectively, increased and decreased activation compared to their relatives and unrelated healthy individuals (Supplemental Table 2). No significant correlation between the PGR-BD score and signal change in the suprathreshold clusters was identified (p \> 0.05).

### 3.4.2. Working memory {#s0100}

No effect of group was noted in the 2-back \> baseline contrast.

4. Discussion {#s0105}
=============

The current study examined the cumulative impact of common risk-alleles for BD, expressed as a polygenic risk score (PGR-BD), on brain activation during facial affect and working memory processing in patients with BD, unaffected relatives and unrelated controls. As expected, the PGR-BD score was higher in BD patients. Relatives had intermediate values that were not statistically different from that of either patients or controls. In line with previous reports ([@bb0330], [@bb0290]), there was a significant effect of PGR-BD on task-related BOLD signal change independent of group but no significant PGR-BD score by group interactions. The current findings therefore support the notion that the polygenic load method is more informative in terms of identifying patterns of neural activation that mediate vulnerability to BD rather than symptom expression. This is consistent with the liability-threshold model of BD since a significant number of risk-alleles are also present in healthy individuals that are unlikely to ever develop BD. Our results also suggest that the effect of polygenic load for BD is not localized to a single region or pathway, irrespective of task. Instead we found that the PGR-BD score influenced task-dependent brain activation.

During the facial affect recognition task, we found a negative association between the PGR-BD score and activation in the visual association cortex. This region is part of the ventral visual pathway, which together with the amygdala and ventral prefrontal regions, form the core facial affect processing network ([@bb0085], [@bb0315]). Reduced visual cortical activation and connectivity during facial affect processing ([@bb0235], [@bb0080]) has been previously reported in patients with BD and have been consistently coupled with increased amygdalar and decreased vlPFC activation ([@bb0040], [@bb0060]). Studies of single SNPs on brain function during emotional processing have found risk-variants to be related to increased amygdalar activation ([@bb0165], [@bb0070], [@bb0295]). However, when considering thousands of risk-conferring alleles, as reflected in the PGR-BD score, we found that their additive effect on the facial affect network involved primarily the recruitment of visual cortical regions. These findings add to the growing evidence of visual information processing abnormalities in patients with BD observed in visual backward masking ([@bb0200]), vernier acuity ([@bb0175]), motion discrimination ([@bb0035], [@bb0215]), context modulation ([@bb0335]) and early visual evoked potentials ([@bb0340]). It is suggested therefore that abnormalities in early sensory processing of affective visual stimuli may contribute to inadequate emotional regulation and predispose individuals to development of the BD.

In the 2-back task, we found a positive association between the PGR-BD score and activation in the ventromedial prefrontal cortex (vmPFC), a brain region integral to the Default Mode Network (DMN), whose activity represents emotional processing during the default state ([@bb0140], [@bb0275]). Typically, vmPFC activation is reduced during cognitively demanding task consistent with the fact that such tasks attenuate emotional processing ([@bb0140]). Failure to deactivate this region has been repeatedly reported in patients with BD both during acute episodes ([@bb0255], [@bb0105]) and during remission ([@bb0250]). Similar abnormalities in the deactivation of the vmPFC have also been reported in unaffected relatives of patients ([@bb0300], [@bb0005]) and have been previously linked to risk-variants in the ANK3 gene ([@bb0055]). Our findings further confirm that abnormalities in suppressing vmPFC activation are likely to represent a genetically mediated vulnerability trait for BD that is linked to greater polygenic load for the disorder.

The main limitation of the current study relates to the sample size which is relatively small for the purposes of genetic studies and could be a potential reason why we did not find any significant group by PGR-BD interaction. On the other hand, the main advantage of the polygenic risk score method is that it provides a quantitative measure of the polygenic load of each study participant without relying on their genetic distance from an affected proband. Moreover, the PGR-BD allows modelling the cumulative effect of multiple risk-variants for BD and is known to explain a greater proportion of phenotypic variance that single riks-alleles ([@bb0160], [@bb0065]).

In conclusion, we demonstrated that the polygenic risk architecture of BD influences the function of regions known to be involved in the sensory and default state processing of emotional information. Functional abnormalities in the visual cortex and ventromedial prefrontal regions of the DMN emerge as genetically influenced vulnerability traits of BD. The current results also indicate that the effect of genetic load for BD on brain function affects task-related recruitment of different brain regions. Future imaging genetics studies with large samples would be uniquely informative in mapping the spatial distribution of the genetic risk to BD on brain processes during various cognitive tasks and may lead to the discovery of biological pathways that may be crucial in mediating the link between genetic factors and alterations in brain networks in this disorder.

Appendix A. Supplementary results {#s0115}
=================================
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![A) Task related activation during the facial affect recognition task (at p \< 0.05 Family Wise Error correction; peak MNI coordinates of suprathreshold clusters in Supplemental Table 1. B) Association between polygenic risk score for bipolar disorder and activation in the visual association cortex.](gr1){#f0005}

![A) Task related activation during the 2-back task (at p \< 0.05 Family Wise Error correction; peak MNI coordinates of suprathreshold clusters in Supplemental Table 1. B) Association between polygenic risk score for bipolar disorder and activation in the ventromedial prefrontal cortex.](gr2){#f0010}

###### 

Sample characteristics.

Table 1

                                                                                   Patients with bipolar disorder (n = 41)   Unrelated controls (n = 46)   Unaffected relatives (n = 25)
  -------------------------------------------------------------------------------- ----------------------------------------- ----------------------------- -------------------------------
  Age (years)                                                                      44.3 (11.9)                               40.3 (13.2)                   39.7 (13.7)
  Sex (male/female)                                                                20/21                                     25/21                         13/12
  IQ                                                                               117.9 (17.9)                              112.6 (14.5)                  115.8 (18.5)
  Polygenic risk score[a](#tf0005){ref-type="table-fn"}                            0.37 (0.04)                               0.32 (0.06)                   0.35 (0.04)
  HDRS total score[b](#tf0010){ref-type="table-fn"}                                4.8 (5.3)                                 0.1 (0.5)                     0.14 (0.4)
  YMRS total score[b](#tf0010){ref-type="table-fn"}                                1.4 (3.0)                                 0.2 (0.6)                     0.0 (0.0)
  BPRS total score[b](#tf0010){ref-type="table-fn"}                                27.5 (4.0)                                24.3 (0.7)                    24.1 (0.4)
  Age of onset (years)                                                             24.7 (8.0)                                --                            --
  Duration of illness (years)                                                      20.2 (10.5)                               --                            --
  Depressive episodes (n)                                                          5.7 (7.5)                                 --                            --
  Manic episodes (n)                                                               5.6 (7.7)                                 --                            --
  Facial affect recognition accuracy (%)                                           90.3 (4.1)                                93.1 (4.8)                    90.1 (5.2)
  Facial affect recognition response time (sec)[c](#tf0015){ref-type="table-fn"}   1.4 (0.20)                                1.10 (0.24)                   1.09 (0.14)
  2-back accuracy (%)                                                              83 (11.6)                                 88 (15.6)                     92.3 (12.5)
  2-back response time (sec)                                                       0.65 (0.19)                               0.63 (0.31)                   0.62 (0.35)

Continuous data are shown as mean (standard deviation); BPRS = Brief Psychiatric Rating Scale; HDRS = Hamilton Depression Rating Scale); YMRS = Young Mania Rating Scale.

Patients \> Controls (p = 0.002).

Patients \> Relatives, Controls (p \< 0.02).

Patients \> Relatives, Controls (p \< 0.007).
